33 analysts are following Baidu and have set target prices ranging from $76.145195 to $159.21521 per share. On average, they have given the company a rating of buy. At today's prices, BIDU is trading ...

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

According to Benzinga Pro, Baidu's peer group average for short interest as a percentage of float is 8.93%, which means the ...

Baidu is working on launching its Apollo Go robotaxi service in Singapore and Malaysia by end-2025, with sources close to the ...

The Roads and Transport Authority of Dubai (RTA) has partnered with Pony.ai to launch driverless taxi trials this year ahead ...